Xenobiotics in Chemical Carcinogenesis: Translational Aspects in Toxicology
Description:
Xenobiotics in Chemical Carcinogenesis: Translational Aspects in Toxicology covers the translational toxicology of xenobiotics substances in carcinogenesis by explaining the toxicokinetic and toxicodynamic, toxicogenomic, biotransformation, and resistance mechanisms in the human body. The book begins with a historical review and link to future prospects for chemical carcinogenesis. It discusses major environmental xenobiotics and their risks in inducing cancer, along with content on toxic xenobiotics and their routes of exposure in humans, the role of xenobiotic metabolism in carcinogenesis, and the toxicokinetic and toxicodynamic of xenobiotics in cancer development.
Lastly, the book explores current achievements such as using toxicogenomics for predicting the carcinogenicity of xenobiotic substances and the challenges posed by carcinogenic xenobiotic substances when examining preventive methods, diagnosis, and the development of anticancer drugs for specific toxicants.
Best prices to buy, sell, or rent ISBN 9780323905602
Frequently Asked Questions about Xenobiotics in Chemical Carcinogenesis: Translational Aspects in Toxicology
The price for the book starts from $150.83 on Amazon and is available from 5 sellers at the moment.
If you’re interested in selling back the Xenobiotics in Chemical Carcinogenesis: Translational Aspects in Toxicology book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Xenobiotics in Chemical Carcinogenesis: Translational Aspects in Toxicology book, the best buyback offer comes from and is $ for the book in good condition.
The Xenobiotics in Chemical Carcinogenesis: Translational Aspects in Toxicology book is in very low demand now as the rank for the book is 11,079,969 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.